Free Trial
OTCMKTS:SHTDF

Sinopharm Group (SHTDF) Stock Price, News & Analysis

Sinopharm Group logo
$2.18 -0.17 (-7.13%)
As of 05/27/2025 03:00 PM Eastern

About Sinopharm Group Stock (OTCMKTS:SHTDF)

Key Stats

Today's Range
$2.18
$2.18
50-Day Range
$2.15
$2.45
52-Week Range
$1.97
$2.83
Volume
1,001 shs
Average Volume
2,250 shs
Market Capitalization
N/A
P/E Ratio
2.19
Dividend Yield
11.91%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. operates as a subsidiary of Sinopharm Industrial Investment Co., Ltd.

Receive SHTDF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sinopharm Group and its competitors with MarketBeat's FREE daily newsletter.

SHTDF Stock News Headlines

Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
Sinopharm Group’s Asset Growth Boosts Investor Confidence
Sinopharm Group Co. Reports Mixed Financial Results
Sinopharm Group Co Ltd ADR X2S1
Sinopharm Group Co Ltd 01099
See More Headlines

SHTDF Stock Analysis - Frequently Asked Questions

Sinopharm Group's stock was trading at $2.49 at the beginning of 2025. Since then, SHTDF stock has decreased by 12.3% and is now trading at $2.1825.
View the best growth stocks for 2025 here
.

Shares of SHTDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Medical Distribution
Sub-Industry
Personal Services
Current Symbol
OTCMKTS:SHTDF
Fax
N/A
Employees
115,959
Year Founded
N/A

Profitability

Trailing P/E Ratio
2.19
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (OTCMKTS:SHTDF) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners